Gennova Bio https://gennova.bio Transforming Healthcare Mon, 04 Nov 2024 10:27:54 +0000 en-GB hourly 1 https://wordpress.org/?v=6.9.1 https://gennova.bio/wp-content/uploads/2020/01/cropped-Gennova-fav-icon-32x32.png Gennova Bio https://gennova.bio 32 32 Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India https://gennova.bio/randomized-parallel-group-open-label-bioequivalence-trial-of-intramuscular-pegaspargase-in-patients-with-relapsed-acute-lymphoblastic-leukemia-2-2/ Mon, 04 Nov 2024 10:26:13 +0000 http://gennova.bio/?p=12712 South Asian J Cancer, 2023 Apr 10;12(4):371-377.
doi: 10.1055/s-0042-1759785

https://pubmed.ncbi.nlm.nih.gov/38130281/

]]> Systematic clinical and pharmacological monitoring of a PEG-asparaginase biogeneric (HAMSYL®) in paediatric patients with newly-diagnosed acute lymphoblastic leukaemia https://gennova.bio/randomized-parallel-group-open-label-bioequivalence-trial-of-intramuscular-pegaspargase-in-patients-with-relapsed-acute-lymphoblastic-leukemia-2/ Mon, 04 Nov 2024 10:22:33 +0000 http://gennova.bio/?p=12709 Pediatr Hematol Oncol. 2023; 8(4):S48. doi: 10.1016/j.phoj.2023.10.122

https://www.sciencedirect.com/science/article/pii/S2468124523001821?via%3Dihub

]]> Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia https://gennova.bio/randomized-parallel-group-open-label-bioequivalence-trial-of-intramuscular-pegaspargase-in-patients-with-relapsed-acute-lymphoblastic-leukemia/ Mon, 20 Jul 2020 11:33:14 +0000 http://gennova.bio/?p=11183 JCO Glob Oncol. 2020 Jul;6:1009-1016. doi: 10.1200/GO.20.00113.

https://pubmed.ncbi.nlm.nih.gov/32628582/

]]> Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): Report of an international collaborative study https://gennova.bio/establishment-of-the-first-international-standard-for-pegylated-granulocyte-colony-stimulating-factor-peg-g-csf-report-of-an-international-collaborative-study/ Thu, 09 Apr 2020 19:23:35 +0000 http://localhost/gennova/?p=10566 J Immunol Methods. 2015 Jan;416:17-28. doi: 10.1016/j.jim.2014.10.005.

https://www.ncbi.nlm.nih.gov/pubmed/25450254

]]> Assessing analytical comparability of biosimilars: GCSF as a case study https://gennova.bio/assessing-analytical-comparability-of-biosimilars-gcsf-as-a-case-study/ Thu, 09 Apr 2020 19:22:10 +0000 http://localhost/gennova/?p=10564 J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 1;1032:165-171. doi: 10.1016/j.jchromb.2016.05.027.

https://www.ncbi.nlm.nih.gov/pubmed/27289250

]]> Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India https://gennova.bio/retrospective-post-marketing-study-on-the-use-of-bio-similar-pegasparagase-among-acute-lymphoblastic-leukemia-patients-in-india/ Thu, 09 Apr 2020 19:21:03 +0000 http://localhost/gennova/?p=10562 Pediatric Hematology Oncology Journal, Volume 3, Issue 1, March 2018, Pages 9-12

https://www.sciencedirect.com/science/article/pii/S2468124517301031

]]> Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity. https://gennova.bio/experience-with-generic-pegylated-l-asparaginase-in-children-with-acute-lymphoblastic-leukemia-and-monitoring-of-serum-asparaginase-activity/ Thu, 09 Apr 2020 19:19:29 +0000 http://localhost/gennova/?p=10560 Pediatr Hematol Oncol. 2018 Aug – Sep;35(5-6):331-340. doi: 10.1080/08880018.2018.1538277

https://www.ncbi.nlm.nih.gov/pubmed/30488741

]]> Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials. https://gennova.bio/efficacy-and-safety-of-intravenous-tenecteplase-bolus-in-acute-ischemic-stroke-results-of-two-open-label-multicenter-trials/ Thu, 09 Apr 2020 18:31:33 +0000 http://localhost/gennova/?p=10554 Am J Cardiovasc Drugs. 2018 Oct;18(5):387-395. doi: 10.1007/s40256-018-0284-1.

https://www.ncbi.nlm.nih.gov/pubmed/29948822

]]> Efficacy and safety of tenecteplase in diabetic and non-diabetic patients of STEMI – Indian registry data https://gennova.bio/efficacy-and-safety-of-tenecteplase-in-diabetic-and-non-diabetic-patients-of-stemi-indian-registry-data/ Thu, 09 Apr 2020 18:29:02 +0000 http://localhost/gennova/?p=10552 J Assoc Physicians India. 2010 Apr;58:229-30.

https://www.ncbi.nlm.nih.gov/pubmed/21046876

]]> Tenecteplase in the treatment of acute pulmonary thrombo-embolism. https://gennova.bio/tenecteplase-in-the-treatment-of-acute-pulmonary-thrombo-embolism/ Thu, 09 Apr 2020 18:28:17 +0000 http://localhost/gennova/?p=10550 J Thromb Thrombolysis. 2011 May;31(4):445-8. doi: 10.1007/s11239-010-0524-y.

https://www.ncbi.nlm.nih.gov/pubmed/20972606

]]>